CrowdStrike (CRWD) Gets Thumbs Up from Oppenheimer—But Here's What the Numbers Actually Show

Oppenheimer just kept its Outperform rating on CrowdStrike Holdings, though the upside looks modest at just 2.19%. Current price sits at $501.31/share, with analysts averaging a $512.28 target (ranging from $186.85 to $741.30).

The Revenue Story vs. Earnings Reality

Projected annual revenue is climbing 9.17% to $4.74B—solid growth. But here’s the catch: non-GAAP EPS is forecast to drop 17.77% to $3.94. That’s a red flag nobody’s talking about.

Institutional Money Is Quietly Bailing Out

Sure, 2,994 funds hold CRWD, but ownership just decreased 0.63% last quarter. More telling: total institutional shares dropped 5.30% to 198.2M.

That put/call ratio of 1.07? Traders are betting bearish.

Who’s Actually Buying?

Vanguard’s index funds (VTSMX and VFINX) increased positions by ~3% each and ramped portfolio allocation by 32%+—classic passive buyer move.

But the real money got cautious: JPMorgan and Jennison both cut their CRWD allocation by 50%+ despite holding positions. Geode Capital also trimmed.

Translation: Institutions are taking profits while pretending they’re still believers.

The Bottom Line

Yes, revenue’s growing. No, earnings aren’t keeping up. Analyst consensus says “hold and nibble,” but smart money is already heading for the exits.